Skip to main content
Log in

Growth curve analysis of asymptomatic and symptomatic meningiomas

  • Clinical Study – Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Meningiomas sometimes appear to stop growing after attaining a large size. Commonly used exponential growth models do not reflect this phenomenon. We attempted to find the best curve to simulate their growth. Fifty-two patients with meningioma were followed up for 3.1–21.7 years (mean 7.5 years) with four or more imaging studies each. Thirty-one patients had asymptomatic tumors. The other 21 patients with residual or recurrent tumor were followed up after surgery. Time–volume curves for each tumor were plotted. Nonlinear regression analyses were performed against power, exponential, logistic, and Gompertzian curves. Time–volume curves corresponded to the Gompertzian and logistic growth curves better than to power or exponential curves. When simulating time–volume curves with Gompertzian curves, the majority of benign meningiomas began to slow their growth before patient age of 80 years. Twenty-three of 31 asymptomatic meningiomas had already passed the inflection point before diagnosis. In contrast, this happened less frequently in symptomatic tumors. Especially, all six atypical meningiomas continued to grow quasi-exponentially. Sigmoid curves that approach a plateau were better descriptors of the growth of benign meningiomas than were curves of unlimited growth. However, atypical meningiomas were unlikely to slow their growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bellular SN, Chandra V (1981) Meningioma size. Its relationship to other diseases. Arch Neurol 38:458–459

    Google Scholar 

  2. Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas in autopsy study. Surg Neurol 27:319–322

    Article  PubMed  CAS  Google Scholar 

  3. Rausing A, Ybo W, Stenflo J (1970) Intracranial meningioma—a population study of ten years. Acta Neurol Scand 46:102–110

    Article  PubMed  CAS  Google Scholar 

  4. Elia-Pasquet S, Provost D, Jaffré A, Loiseau H, Vital A, Kantor G, Maire JP, Dautheribes M, Darrouzet V, Dartigues JF, Brochard P, Baldi I, Work Group (2004) Incidence of central nervous system tumors in Gironde, France. Neuroepidemiology 23:110–117

    Article  PubMed  Google Scholar 

  5. Kuratsu J, Takeshima H, Ushio Y (2001) Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Oncol 6:183–191

    CAS  Google Scholar 

  6. Radhakrishnan K, Mokri B, Parisi JE, O’Fallon WM, Sunku J, Kurland LT (1995) The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 37:67–73

    Article  PubMed  CAS  Google Scholar 

  7. Go RS, Taylor BV, Kimmel DW (1998) The natural history of asymptomatic meningiomas in Olmstead County, Minnesota. Neurology 51:1718–1720

    PubMed  CAS  Google Scholar 

  8. Yano S, Kuratsu J, The Kumamoto Brain Tumor Research Group (2006) Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105:538–543

    Article  PubMed  Google Scholar 

  9. Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir 142:507–511

    Article  CAS  Google Scholar 

  10. Hashiba T, Hashimoto N, Izumoto S, Suzuki T, Kagawa N, Maruno M, Kato A, Yoshimine T (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110:675–684

    Article  PubMed  Google Scholar 

  11. Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G (2004) Natural history of conservatively treated meningiomas. Neurology 63:1133–1134

    PubMed  CAS  Google Scholar 

  12. Jung HW, Yoo H, Paek SH, Choi KS (2000) Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery 46:567–574

    Article  PubMed  CAS  Google Scholar 

  13. Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53:62–70

    Article  PubMed  Google Scholar 

  14. Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:224–226

    Google Scholar 

  15. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiat 68:25–28

    Article  PubMed  CAS  Google Scholar 

  16. Nakasu S, Fukami T, Nakajima M, Watanabe K, Ichikawa M, Matsuda M (2005) Growth pattern changes of meningiomas: long-term growth analysis. Neurosurgery 56:946–955

    PubMed  Google Scholar 

  17. Cho KG, Hoshino T, Nagashima T, Murovic JA, Wilson CB (1986) Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling. J Neurosurg 65:790–794

    Article  PubMed  CAS  Google Scholar 

  18. Jääskeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165–172

    Article  PubMed  Google Scholar 

  19. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254

    Article  PubMed  CAS  Google Scholar 

  20. Van Havenbergh T, Carvalho G, Tatagiba M, Plets C, Samii M (2003) Natural history of petro-clival meningioma. Neurosurgery 52:55–64

    Article  PubMed  Google Scholar 

  21. Nakasu S, Nakasu Y, Nakajima M, Yokoyama M, Matsuda M, Handa J (1996) Potential doubling time and tumor doubling time in meningiomas and neurinomas. Acta Neurochir 138:763–770

    Article  CAS  Google Scholar 

  22. Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 164–172

    Google Scholar 

  23. Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2005) Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas. Zentralbl Neurochir 66:17–23

    Article  PubMed  CAS  Google Scholar 

  24. Castro MAA, Klamt F, Grieneisen VA, Grivicich I, Moreira JCF (2003) Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines. Cell Prolif 36:65–73

    Article  PubMed  CAS  Google Scholar 

  25. Demicheli R, Foroni R, Ingrosso A, Pratesi G, Soranzo C, Tortoreto M (1989) An experimental Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res 49:6543–6546

    PubMed  CAS  Google Scholar 

  26. Norton L (1988) A Gompertzian model of human breast cancer growth. Cancer Res 48:7067–7071

    PubMed  CAS  Google Scholar 

  27. Steel GG, Lametron LF (1966) The growth of human tumors. Br J Cancer 20:74–86

    Article  PubMed  CAS  Google Scholar 

  28. Hart D, Shochat E, Agur Z (1998) The growth law of primary breast cancer as inferred from mammography screening trial data. Br J Cancer 78:382–387

    Article  PubMed  CAS  Google Scholar 

  29. Norton L, Simon R, Brereton H, Bodgen AE (1976) Predicting the course of Gompertzian growth. Nature 264:542–545

    Article  PubMed  CAS  Google Scholar 

  30. Speer JF, Petrosky VE, Retsky MW, Wardwell RH (1984) A stochastic numerical model of breast cancer growth that simulates clinical data. Cancer Res 44:4124–4130

    PubMed  CAS  Google Scholar 

  31. Gyllenberg M, Webb GF (1989) Quiescence as an explanation of Gompertzian tumor growth. Growth Develop Aging 53:25–33

    CAS  Google Scholar 

  32. Kozusko F, Bourdeau M (2007) A unified model of sigmoid tumour growth based on cell proliferation and quiescence. Cell Prolif 40:824–834

    Article  PubMed  CAS  Google Scholar 

  33. Kozusko F, Bajzer Z (2003) Combining Gompertzian growth and cell population dynamics. Math Biosci 185:153–167

    Article  PubMed  Google Scholar 

  34. Lazareff JA, Suwinski R, De Rosa R, Olmstead CE (1999) Tumor volume and growth kinetics in hypothalamic-chiasmatic pediatric low grade gliomas. Pediatr Neurosurg 30:312–319

    Article  PubMed  CAS  Google Scholar 

  35. Schiffer D, Ghimenti C, Fiano V (2005) Absence of histological signs of tumor progression in recurrences of completely resected meningiomas. J Neuro-oncol 73:125–130

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Nakasu.

Appendix

Appendix

Growth curve equations used in this article are shown below, where α, β, and γ are constants, and V(t) is the volume at time t.

$$ {\text{Exponential curve}}: \, V(t) = \alpha \beta^{t} + \gamma $$

Power curve [28] : \(V(t)\, = \,\left( {\alpha t\left( {1 - \beta } \right) + \gamma } \right)^{1/1 - \beta } \)

The power curves show rapid increase of volume when 0 < β < 1, linear growth when β = 0, and gradual deceleration when β < 0.

$$ {\text{Logistic curve : }}V(t)\, = \;\gamma /\left( {1 + \alpha \exp \left( { - \beta t} \right)} \right) $$
$$ {\text{Gompertzian curve}}: \, V(t)\, = \,\alpha \exp \left( { - \beta \exp \left( { - \gamma t} \right)} \right) $$
$$ {\text{Inflection point}}: \, Ti\, = \,\left( {\ln \left( {\alpha /\beta } \right)} \right)/\beta $$

Ti was described as days after the initial observation time. A negative Ti value indicates that the inflection point was before the initial imaging study. However, if Ti is beyond the observation period, the tumor was still growing quasi-exponentially.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakasu, S., Nakasu, Y., Fukami, T. et al. Growth curve analysis of asymptomatic and symptomatic meningiomas. J Neurooncol 102, 303–310 (2011). https://doi.org/10.1007/s11060-010-0319-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0319-1

Keywords

Navigation